Identification of novel p-cresol inhibitors that reduce Clostridioides difficile's ability to compete with species of the gut microbiome (2023)

First Author: Harrison M
Attributed to:  LY256: A novel and potent antibiotic for treating Clostridium difficile infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-32656-8

PubMed Identifier: 37303029

Publication URI: http://europepmc.org/abstract/MED/37303029

Type: Journal Article/Review

Parent Publication: Scientific Reports

Issue: 1